opc 12759 has been researched along with Alloxan Diabetes in 1 studies
rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic administration of rebamipide (100 mg/kg/day, p." | 1.30 | Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor-beta and fibronectin, and lipid peroxidation induced by high glucose in cultured mesangial cells. ( Ha, H; Kim, KH; Lee, SH, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ha, H | 1 |
| Lee, SH | 1 |
| Kim, KH | 1 |
1 other study available for opc 12759 and Alloxan Diabetes
| Article | Year |
|---|---|
Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor-beta and fibronectin, and lipid peroxidation induced by high glucose in cultured mesangial cells.
Topics: Alanine; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Fibronectins; | 1997 |